Literature DB >> 26659400

Epigenetics in the Neoliberal "Regime of Truth": A Biopolitical Perspective on Knowledge Translation.

Charles Dupras, Vardit Ravitsky.   

Abstract

Recent findings in epigenetics have been attracting much attention from social scientists and bioethicists because they reveal the molecular mechanisms by which exposure to socioenvironmental factors, such as pollutants and social adversity, can influence the expression of genes throughout life. Most surprisingly, some epigenetic modifications may also be heritable via germ cells across generations. Epigenetics may be the missing molecular evidence of the importance of using preventive strategies at the policy level to reduce the incidence and prevalence of common diseases. But while this "policy translation" of epigenetics introduces new arguments in favor of public health strategies and policy-making, a more "clinical translation" of epigenetics is also emerging. It focuses on the biochemical mechanisms and epigenetic variants at the origin of disease, leading to novel biomedical means of assessing epigenetic susceptibility and reversing detrimental epigenetic variants. In this paper, we argue that the impetus to create new biomedical interventions to manipulate and reverse epigenetic variants is likely to garner more attention than effective social and public health interventions and therefore also to garner a greater share of limited public resources. This is likely to happen because of the current biopolitical context in which scientific findings are translated. This contemporary neoliberal "regime of truth," to use a term from Michel Foucault, greatly influences the ways in which knowledge is being interpreted and implemented. Building on sociologist Thomas Lemke's Foucauldian "analytics of biopolitics" and on literature from the field of science and technology studies, we present two sociological trends that may impede the policy translation of epigenetics: molecularization and biomedicalization. These trends, we argue, are likely to favor the clinical translation of epigenetics-in other words, the development of new clinical tools fostering what has been called "personalized" or "precision" medicine. In addition, we argue that an overemphasized clinical translation of epigenetics may further reinforce this biopolitical landscape through four processes closely related to neoliberal pathways of thinking: the internalization and isolation (aspects of liberal individualism) of socioenvironmental determinants of health and increased opportunities for commodification and technologicalization (aspects of economic liberalism) of health care interventions.
© 2015 The Hastings Center.

Entities:  

Mesh:

Year:  2015        PMID: 26659400     DOI: 10.1002/hast.522

Source DB:  PubMed          Journal:  Hastings Cent Rep        ISSN: 0093-0334            Impact factor:   2.683


  6 in total

1.  The paradox of care in behavioral epigenetics: Constructing early-life adversity in the lab.

Authors:  Martine Lappé
Journal:  Biosocieties       Date:  2018-05-09

2.  Epigenetics, Media Coverage, and Parent Responsibilities in the Post-Genomic Era.

Authors:  Martine Lappé
Journal:  Curr Genet Med Rep       Date:  2016-06-14

Review 3.  Transgenerational epigenetics and environmental justice.

Authors:  Mark A Rothstein; Heather L Harrell; Gary E Marchant
Journal:  Environ Epigenet       Date:  2017-08-03

Review 4.  Epigenetics, ethics, law and society: A multidisciplinary review of descriptive, instrumental, dialectical and reflexive analyses.

Authors:  Charles Dupras; Katie Michelle Saulnier; Yann Joly
Journal:  Soc Stud Sci       Date:  2019-08-01       Impact factor: 3.885

5.  Epigenetic Discrimination: Emerging Applications of Epigenetics Pointing to the Limitations of Policies Against Genetic Discrimination.

Authors:  Charles Dupras; Lingqiao Song; Katie M Saulnier; Yann Joly
Journal:  Front Genet       Date:  2018-06-08       Impact factor: 4.599

Review 6.  Ethical implications of epigenetics in the era of personalized medicine.

Authors:  Josep Santaló; María Berdasco
Journal:  Clin Epigenetics       Date:  2022-03-25       Impact factor: 6.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.